Christopher Kuebler Biography and Net Worth

Director of Waters

Christopher A. Kuebler is Independent Director of Waters Corporation, since May 2006. He has been an independent director and investor since 2006. He served as Chairman and Chief Executive Officer of Covance Inc. and its predecessor companies from November 1994 to December 2004 and as Chairman during 2005. Prior to joining Covance, Inc., Mr. Kuebler spent nearly 20 years in the pharmaceutical industry at Abbott Laboratories, Squibb, Inc. and the Monsanto Company. With 30 years of experience in the pharmaceutical and pharmaceutical service industries, including 10 years as Chairman and Chief Executive Officer of Covance Inc., Mr. Kuebler brings an experienced management perspective to the Waters Board, as well as the expertise in the oversight of financial accounting and business strategy.

What is Christopher A. Kuebler's net worth?: The estimated net worth of Christopher A. Kuebler is at least $5.39 million as of May 15th, 2024. Mr. Kuebler owns 14,716 shares of Waters stock worth more than $5,393,120 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Kuebler may own. Learn More about Christopher A. Kuebler's net worth.
How do I contact Christopher A. Kuebler?: The corporate mailing address for Mr. Kuebler and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Christopher A. Kuebler's contact information.
Has Christopher A. Kuebler been buying or selling shares of Waters?: Christopher A. Kuebler has not been actively trading shares of Waters during the past quarter. Most recently, Christopher A. Kuebler sold 4,000 shares of the business's stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a transaction totalling $1,446,560.00. Following the completion of the sale, the director now directly owns 14,716 shares of the company's stock, valued at $5,321,894.24. Learn More on Christopher A. Kuebler's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $332,900.00. During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,624,330.00. The most recent insider tranaction occured on May, 28th when Director Richard H Fearon bought 1,000 shares worth more than $332,900.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 5/28/2024.

Christopher A. Kuebler Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2024	Sell	4,000	$361.64	$1,446,560.00	14,716
8/4/2023	Sell	4,000	$291.48	$1,165,920.00	14,382
5/19/2022	Sell	4,000	$328.78	$1,315,120.00	14,064
8/18/2021	Sell	3,000	$405.62	$1,216,860.00	13,763
11/16/2018	Sell	8,000	$199.67	$1,597,360.00	18,911
3/8/2018	Sell	416	$209.00	$86,944.00	15,327
8/8/2017	Sell	3,500	$179.67	$628,845.00	17,849
5/4/2016	Sell	4,000	$129.88	$519,520.00	20,461
11/23/2015	Sell	4,000	$133.17	$532,680.00	12,700

Christopher A. Kuebler Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $366.48

$357.41

$367.09

50 Day Range

MA: $352.17

$322.08

$387.34

2 Week Range

Now: $366.48

$273.60

$393.38

Volume

106,082 shs

Average Volume

434,882 shs

Market Capitalization

$21.76 billion

P/E Ratio

34.97

Dividend Yield

N/A

Beta

0.97

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.